Skip to main content
Clinical Trials/ITMCTR2000003232
ITMCTR2000003232
Completed
未知

Research for Chinese medicine rehabilitation program in the treatment of hemiplegia spasm in apoplexy

Dongzhimen Hospital, Beijing University of Chinese Medicine0 sitesTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Dongzhimen Hospital, Beijing University of Chinese Medicine
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Dongzhimen Hospital, Beijing University of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\. meet the diagnostic criteria of ischemic stroke;
  • 2\. The CT/MRI examination conforms to the diagnostic criteria of western medicine for cerebral infarction;
  • 3\. aged 35 to 75 years;
  • 4\. within 3 months of onset, the vital signs are stable;
  • 5\. NIHSS assessment 4\-24;
  • 6\. levels out the stroke recovery in II\-IV;
  • 7\. All landowners modified Ashworth spasm evaluation method to evaluate paralyzed limb muscle tension levels \> 0 and IV or less;
  • 8\. The patient himself or his relatives sign the informed consent.

Exclusion Criteria

  • 1\. subarachnoid hemorrhage, cerebral hemorrhage (ICH), transient ischemic attack (TIA);
  • 2\. previous motor dysfunction, such as rheumatoid arthritis, joint deformity and neuromuscular lesions and other diseases that have a direct impact on motor function;
  • 3\. with disrecognition, apraxia and other functional disorders that cannot be combined with rehabilitation training;
  • 4\. non\-atherosclerotic thrombotic cerebral infarction (such as cardiogenic embolism, coagulation status, endovascular shedding, arteritis, etc.);
  • 5\. serious heart disease, heart, liver, kidney failure, malignant tumor, gastrointestinal bleeding;
  • Pregnant and lactating women;
  • 6\. Those who cannot actively cooperate with rehabilitation treatment;
  • 7\. Being participating in other clinical trials that affect the evaluation of the results of this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials